EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT01360827 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated due to potential safety concerns in combination with platinum-based therapies

Conditions

Interventions

Sponsor

Merck KGaA, Darmstadt, Germany